Objective To evaluate the clinical efficacy and safety of modified Da Chaihu Tang (Modified Major Bupleurum Decoction) in the treatment of hyperlipidemia (syndrome of phlegm and blood stasis obstructing the interior). Methods A total of 102 patients with hyperlipidemia (syndrome of phlegm and blood stasis obstructing the interior) who visited Dazhigu Street Community Health Service Center, Hedong District, Tianjin, from February 2023 to October 2024 were enrolled and assigned to an observation group and a control group using a random number table, with 51 patients in each group. Both groups received lifestyle interventions, the control group received oral simvastatin (once daily, 20 mg per dose), and the observation group received modified Da Chaihu Tang (1 dose daily, taken orally in 2 divided doses). Both groups were treated continuously for 8 weeks. Lipid levels before and after treatment, clinical efficacy, traditional Chinese medicine (TCM) syndrome efficacy, and adverse reactions during treatment were compared between the two groups. Results Before treatment, no significant between-group differences were found in serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), lipoprotein (a), apolipoprotein B (ApoB), or apolipoprotein A1 levels (all P>0.05). After 8 weeks of treatment, serum TC, TG, LDL-C, and ApoB levels decreased in both groups, and serum HDL-C levels increased in both groups (all P<0.05). Serum TC, TG, and LDL-C levels in the observation group were lower than those in the control group, and serum HDL-C levels were higher than those in the control group (all P<0.05). No significant between-group difference was observed in the overall clinical response rate (P>0.05). The overall response rate of TCM syndromes in the observation group was higher than that in the control group (94.12% vs. 78.43%, P<0.05), and the incidence of adverse reactions during treatment was lower than that in the control group (3.92% vs. 15.69%, P<0.05). Conclusion Modified Da Chaihu Tang can improve lipid levels and TCM syndromes in patients with hyperlipidemia (syndrome of phlegm and blood stasis obstructing the interior), with a favorable safety profile.